# Continuous monitoring of serum markers for early detection of periprosthetic joint infection in osteoporotic patients undergoing hip arthroplasty: A prospective cohort study

**Authors:** Panfeng Wang, Dayuan Xu, Yan Xia, Yuntong Zhang, Yongming Sun

PMC · DOI: 10.5937/jomb0-57013 · Journal of Medical Biochemistry · 2026-01-06

## TL;DR

This study evaluates serum markers for early detection of joint infections in osteoporotic patients after hip surgery, finding that certain markers reliably detect infections early.

## Contribution

The study introduces a reliable combination of serum markers for early detection of periprosthetic joint infection in osteoporotic patients.

## Key findings

- CRP, PCT, ESR, D-dimer, WBC, sCD14, and SAA were significantly higher in infected patients at 48 hours post-surgery.
- A combination of CRP, D-dimer, WBC, sCD14, and SAA achieved 90% sensitivity and 92% specificity for PJI detection.
- Ferritin and MMP-9 showed higher values in infected patients but did not reach statistical significance.

## Abstract

Periprosthetic joint infection (PJI) is a significant complication following hip arthroplasty, especially in osteoporotic patients. Early detection is crucial for improving outcomes but remains challenging. This study assesses the effectiveness of continuous monitoring of serum markers - C-reactive protein (CRP), procalcitonin (PCT), erythrocyte sedimentation rate (ESR), D-dimer, white blood cell count (WBC), ferritin, soluble CD14 (sCD14), matrix metalloproteinase-9 (MMP-9), and serum amyloid A (SAA) - for early detection of PJI in osteoporotic patients undergoing hip arthroplasty.

A prospective cohort study included 150 osteoporotic patients undergoing hip arthroplasty. Inflammatory markers were measured preoperatively and at 24-, 48-, and 72 hours post-surgery, with weekly follow-ups for 6 weeks. PJI was diagnosed based on clinical, microbiological, and imaging criteria. The diagnostic performance of individual markers was assessed using Receiver Operating Characteristic (ROC) curves.

Among the 150 patients, 12 (8%) developed PJI within 6 weeks. At 48 hours post-surgery, CRP PCT, ESR, D-dimer, WBC, sCD14, and SAA were significantly higher in the PJI group compared to the non-infected group (p&lt; 0.05 for all). Ferritin and MMP-9 levels showed higher values in the infected group but did not reach statistical significance (p= 0.076 and p= 0.094, respectively). The combination of CRP D-dimer, WBC, sCD14, and SAA demonstrated 90% sensitivity and 92% specificity for PJI detection.

Continuous monitoring of CRP, D-dimer, WBC, sCD14, and SAA offers a reliable approach for early detection of PJI in osteoporotic patients undergoing hip arthroplasty. These markers showed strong associations with infection, while ferritin and MMP-9 were less informative. This strategy may help improve early diagnosis and patient outcomes.

## Linked entities

- **Proteins:** ferritin (soma ferritin-like)
- **Diseases:** periprosthetic joint infection (MONDO:0800179), osteoporosis (MONDO:0005298)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, CD14 (CD14 molecule) [NCBI Gene 929], IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, SAA [NCBI Gene 6287], CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}
- **Diseases:** hip fracture (MESH:D006620), blood disorders (MESH:D006402), hypertension (MESH:D006973), immune dysfunction (MESH:D007154), bacteremia (MESH:D016470), infected (MESH:D007239), Osteoporosis (MESH:D010024), impaired bone healing (MESH:D001847), bone erosion (MESH:D014077), bacterial infections (MESH:D001424), lymphoma (MESH:D008223), allergies (MESH:D004342), leukaemia or (MESH:D015458), septic arthritis (MESH:D001170), immune dysregulation (OMIM:614878), HIV (MESH:D015658), Infectious Diseases (MESH:D003141), cognitive impairment (MESH:D003072), abscess (MESH:D000038), Inflammatory (MESH:D007249), degenerative hip diseases (MESH:D019636), Trauma (MESH:D014947), pain (MESH:D010146), fractures (MESH:D050723), bacteria (MESH:C000719206), cancer (MESH:D009369), diabetes (MESH:D003920), liver or renal failure (MESH:D051437), Osteoporotic (MESH:D058866), swelling (MESH:D004487), Impaired bone metabolism (MESH:D001851), hip (MESH:D025981), fever (MESH:D005334), osteoarthritis (MESH:D010003), PJI (MESH:D057068)
- **Chemicals:** cefazolin (MESH:D002437), lipopolysaccharides (MESH:D008070), clindamycin (MESH:D002981), iron (MESH:D007501)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967202/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967202/full.md

---
Source: https://tomesphere.com/paper/PMC12967202